2014
DOI: 10.4161/21624011.2014.955343
|View full text |Cite
|
Sign up to set email alerts
|

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 10 publications
(9 reference statements)
0
3
0
Order By: Relevance
“…Two experimental models were designed by Werter et al to eliminate cancer cells via Vγ9Vδ2 T-cell/BTN3A1, which is working as an antigen presenting cell for the invariant natural killer T-cells (iNKT) [ 163 ]. Both approaches were shown to result in the Vγ9Vδ2 T-cells that have the capacity to act as antigen presenting cells for iNKT via trogocytosis of membrane-associated antigens, which can act as APS to propagate Th1 biased anti-tumor immune responses within tumor microenvironment [ 163 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Two experimental models were designed by Werter et al to eliminate cancer cells via Vγ9Vδ2 T-cell/BTN3A1, which is working as an antigen presenting cell for the invariant natural killer T-cells (iNKT) [ 163 ]. Both approaches were shown to result in the Vγ9Vδ2 T-cells that have the capacity to act as antigen presenting cells for iNKT via trogocytosis of membrane-associated antigens, which can act as APS to propagate Th1 biased anti-tumor immune responses within tumor microenvironment [ 163 ].…”
Section: Discussionmentioning
confidence: 99%
“…Two experimental models were designed by Werter et al to eliminate cancer cells via Vγ9Vδ2 T-cell/BTN3A1, which is working as an antigen presenting cell for the invariant natural killer T-cells (iNKT) [ 163 ]. Both approaches were shown to result in the Vγ9Vδ2 T-cells that have the capacity to act as antigen presenting cells for iNKT via trogocytosis of membrane-associated antigens, which can act as APS to propagate Th1 biased anti-tumor immune responses within tumor microenvironment [ 163 ]. These models are in agreement with the previous studies, which demonstrated that the PAg-induced Vγ9Vδ2 T-cells could recognize and kill a variety of cancer cells both in vitro as well as in vivo, such as nasopharyngeal, colon, pancreatic adenocarcinomas, breast carcinoma, melanoma, as well as the large number of hematological tumors [ 155 , 164 , 165 , 166 , 167 ].…”
Section: Discussionmentioning
confidence: 99%
“…These cells play different roles in the immune response, such as cytokine production, antigen presentation, killer cell activity enhancement, and immune cell regulation ( 43 ). In contrast to αβT cells, γδT cells are not limited by APCs, which have the ability to recognize danger signals and then activate targeted cells ( 51 , 52 ). Crowley et al.…”
Section: The Roles and Functions Of γδ T Lymphocytes In Innate And Ad...mentioning
confidence: 99%